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Results (cont.)

Materials and Methods (cont.)

• Cannabis in the most commonly abused illicit drug in the
world
• In the U.S., 33 states have legalized medicinal marijuana use
and 11 states and the District of Columbia have legalized
recreational marijuana use
• As medical and recreational uses of this substance become
increasingly legal, there is a need for reliable analytical
methods that can detect and analyze cannabinoids in death
cases where there is a question relating to the cause and
manner of death when typical matrices are not available
• Vitreous humor is a gelatinous fluid located in the eyeball that
is used as a matrix to test for drugs and alcohol
• In this study, a method was developed and validated to
quantitate THC, 11-OH-THC, THCCOOH, and CBD in vitreous
humor and whole blood utilizing a liquid-liquid extraction and
analysis by LC-MS/MS
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• Table 2: Optimized MS parameters.
Parameter
Positive spray voltage (V)
Negative spray voltage (V)
Sheath gas
Aux gas
Sweep gas
Ion transfer tube
temperature (⁰C)
Vaporizer temperature (⁰C)

4000
2500
30
12
2
375
425

11-OH-THC

THC

Figure 6. Quantitative ion peak (left) and confirmatory ion peak (right) for THCCOOH in vitreous
case sample.
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Method Validation

Figure 1. Cannabinoids included in developed method.

Materials and Methods

• Method validated according to SWG TOX validation guidelines
• Precision, accuracy, ion suppression, and interferences
evaluated by various experiments
• Method was fully validated in vitreous fluid and cross validated
into whole blood
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Liquid-Liquid Extraction
1 mL of bovine
vitreous humor or
vitreous sample
added to test tubes

800 μL of 10% acetic
acid added to
samples and vortexed

100 μL of internal
standard and 100 μL
of calibrators or QC
material added to
samples

2 mL of water added
to samples and
vortexed

8 mL of hexanes and
ethyl acetate (9:1)
added to samples

Sample tubes capped
and rotated for 30
minutes and
centrifuged at 2800
rpm for 15 minutes
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Figure 3. Ion suppression study results.

• In 5 of the 7 cases analyzed, trace levels of THCCOOH were
detected in the vitreous sample below the LOQ (5 ng/mL)
• Possible to confirm that THCCOOH is present due to passing
ion ratios and consistent retention times
• Blood and vitreous cannabinoid concentrations considerably
different

• Area count for each analyte required to be <25% of the LOQ
for that analyte
• Interference seen from 11-OH-THC-d3 likely due to isotope of
this analyte
• Parallel studies performed to show that ion suppression not
affecting quantitation

Area Counts

CBD

THCCOOH

Results (cont.)

• Table 3. LOQs for all analytes.
Analyte
LOQ (ng/mL)
THC
0.5
11-OH-THC
0.5
THCCOOH
5
CBD
0.5
• Ion suppression was required to be within ±25%
• All analytes fell above the upper limit of 25%
• Parallel studies performed to show that ion suppression not
affecting quantitation

• Table 1. Chromatographic elution gradient.
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Discussion and Conclusions

• A method was developed and validated to quantitate THC,
11-OH-THC, THCCOOH, and CBD in vitreous fluid and whole
blood by LC-MS/MS
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• Casework samples showed that blood samples testing
Figure 4. Interference study results.
positive for cannabinoids have a positive correlation for
trace levels of THCCOOH in vitreous humor
• Method was tested for interferences with a fentanyl drug
• Low levels of cannabinoids in vitreous humor could be due
panel (FEN2), a hallucinogenic drug panel (HAL), a
to the compounds being mostly water insoluble or some
benzodiazepine panel (BZE), an antihistamine panel (AHS), and
other postmortem mechanism
an antipsychotic medication panel (APS)
• All analytes within a 20% difference of target concentration in
the presence of these other analytes
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Sample Analysis
• All analysis performed with a Phenomenex Kinetex C18 (2.1x100
mm, 2.6 μm particle size) with Vanquish High Pressure Liquid
Chromatography System
• Identification/quantitation performed with a TSQ Endura QqQ
Mass Spectrometer operating in selective reaction monitoring
mode
• Gradient elution performed with acetonitrile (Mobile Phase A)
and 0.1% formic acid in water (Mobile Phase B)
• SRM transitions optimized by direct infusion
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Figure 2. Total ion chromatogram of all four analytes using developed method.
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Figure 5. Cross panel interference study results.

• Precision experiment showed that all analytes have a
coefficient of variance within 20% of target concentration
• Accuracy experiment showed that analytes typically have an
overall bias within 20% of target concentration
• Limit of quantitation (LOQ) for each analyte established based
on lowest concentration at which analyte passes both
precision and accuracy criteria

Comparison of Blood-Vitreous Concentrations
• Seven forensic casework samples extracted for
comparison
• Blood samples showed amounts of THC (ranging from .718.3 ng/mL), 11-OH-THC (ranging from 0.51-1.7 ng/mL),
and THCCOOH (ranging from 9.6-32.2 ng/mL)
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